Non Serious Adverse Drug Reactions Report

Start Date:2016-04-11 End Date:2016-04-12
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0210Subject Initials :GLWDOB :05/08/1983Sex:FemaleRace:AsianHeight:160cmWeight:55.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/28/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/15/201509/20/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: the right fallopian tube obstructionUk-Unk-2014Not on treatment/medication
 



11-APR-16
NA/EMR700623-541/C02-0210
Page 1 of 25
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-11 End Date:2016-04-12
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0215Subject Initials :L-XDOB :08/05/1989Sex:FemaleRace:AsianHeight:165cmWeight:56.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/28/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/14/201509/18/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal occlusion Uk-Unk-2014Not on treatment/medication
Under laparoscopy surgery to clear the fallopian tubes, pelvic adhesions dissectionUk-Unk-2014Not on treatment/medication
 



11-APR-16
NA/EMR700623-541/C02-0215
Page 2 of 25
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-11 End Date:2016-04-12
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0217Subject Initials :YQXDOB :02/10/1987Sex:FemaleRace:AsianHeight:157cmWeight:60.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/31/2015187.5
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/15/201509/20/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy therapy chemotherapy to kill embryos Uk-Unk-2011Not on treatment/medication
HSG: bilateral tubal obstruction.Uk-Unk-2010Not on treatment/medication
Laparoscopy surgery: pelvic adhesions dissection, bilateral tubal surgery to clearUk-Unk-2010Not on treatment/medication
 



11-APR-16
NA/EMR700623-541/C02-0217
Page 3 of 25
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-11 End Date:2016-04-12
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0219Subject Initials :YLZDOB :06/17/1986Sex:FemaleRace:AsianHeight:160cmWeight:46.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/31/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/15/201509/20/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal obstruction. Uk-Unk-2011Not on treatment/medication
HSG: bilateral tubal patency, pelvic adhesions. Uk-Unk-2014Not on treatment/medication
 



11-APR-16
NA/EMR700623-541/C02-0219
Page 4 of 25
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-11 End Date:2016-04-12
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0220Subject Initials :CCTDOB :05/15/1985Sex:FemaleRace:AsianHeight:152cmWeight:51.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/31/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/15/201509/20/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal patency. Uk-Unk-2014Not on treatment/medication
 



11-APR-16
NA/EMR700623-541/C02-0220
Page 5 of 25
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-11 End Date:2016-04-12
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0222Subject Initials :YMDDOB :04/19/1983Sex:FemaleRace:AsianHeight:158cmWeight:42.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/31/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/16/201509/20/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: the side of tubal passable. Uk-Unk-2012Not on treatment/medication
Laparoscopic surgery: bilateral tubal surgery, right fallopian tube patency.Uk-Unk-2012Not on treatment/medication
 



11-APR-16
NA/EMR700623-541/C02-0222
Page 6 of 25